Clean Yield Group Novartis Ag Transaction History

Clean Yield Group

$296 Million
Q3 2024

A detailed history of Clean Yield Group transactions in Novartis Ag stock. As of the latest transaction made, Clean Yield Group holds 374 shares of NVS stock, worth $36,782. This represents 0.01% of its overall portfolio holdings.

Number of Shares

374

Holding current value

$36,782

% of portfolio

0.01%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$106.13 - $120.89 $39,692 - $45,212	374 New	374 $43,000
Q4 2020 Jan 26, 2021	SELL	$78.07 - $94.43 $2,029 - $2,455	-26 Closed	0 $0
Q3 2020 Oct 16, 2020	BUY	$82.14 - $91.0 $2,135 - $2,366	26 New	26 $2,000
Q1 2020 Apr 20, 2020	SELL	$70.67 - $99.01 $777 - $1,089	-11 Closed	0 $0
Q4 2019 Jan 17, 2020	SELL	$84.35 - $95.37 $19,653 - $22,221	-233 Reduced 95.49%	11 $1,000
Q3 2019 Oct 23, 2019	BUY	$85.54 - $94.26 $7,270 - $8,012	85 Added 53.46%	244 $21,000
Q2 2019 Jul 22, 2019	BUY	$75.4 - $92.8 $11,988 - $14,755	159 New	159 $15,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clean Yield Group, based on Form 13F filings with the SEC.

News

Stay updated on Clean Yield Group with notifications on news.

Account